Authors: Bendele, AM Chlipala, ES Scherrer, J Frazier, J Sennello, G Rich, WJ Edwards, CK

Citation: Am. Bendele et al., Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis, ARTH RHEUM, 43(12), 2000, pp. 2648-2659

Authors: Bendele, A Sennello, G McAbee, T Frazier, J Chlipala, E Rich, B

Citation: A. Bendele et al., Effects of interleukin 1 receptor antagonist alone and in combination withmethotrexate in adjuvant arthritic rats, J RHEUMATOL, 26(6), 1999, pp. 1225-1229

Authors: Bendele, A McComb, J Gould, T McAbee, T Sennello, G Chlipala, E Guy, M

Citation: A. Bendele et al., Animal models of arthritis: Relevance to human disease, TOX PATHOL, 27(1), 1999, pp. 134-142

Authors: Bendele, A McAbee, T Sennello, G Frazier, J Chlipala, E McCabe, D

Citation: A. Bendele et al., Efficacy of sustained blood levels of interleukin-1 receptor antagonist inanimal models of arthritis - Comparison of efficacy in animal models with human clinical data, ARTH RHEUM, 42(3), 1999, pp. 498-506